Last reviewed · How we verify
NCT05494281: USB22
Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer
NA trial testing Serratus Anterior Plane Block with local anesthetic in Breast Neoplasms in 94 participants. Status unknown.
1 February 2023
Quick facts
| Lead sponsor | Moroccan Society of Surgery |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 94 |
| Start date | 1 August 2022 |
| Primary completion | 1 February 2023 |
| Estimated completion | 31 July 2023 |
| Sites | 1 location across Morocco |
Drugs / interventions tested
- Serratus Anterior Plane Block with local anesthetic
- Serratus Anterior Plane Block with saline solution
Conditions studied
- Breast Neoplasms — all drugs for Breast Neoplasms →
- Pain, Postoperative — all drugs for Pain, Postoperative →
- Pain, Chronic — all drugs for Pain, Chronic →
- Post-Mastectomy Chronic Pain Syndrome — all drugs for Post-Mastectomy Chronic Pain Syndrome →
Sponsor
Moroccan Society of Surgery
Who can join
Adults 18 to 70, female only, with Breast Neoplasms or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic postoperative pain (CPP) remains a disturbing and obscure clinical problem. The hypothesis of this trial is that a peripheral block of the serratus anterior plane block type preoperatively after a modified radical mastectomy makes it possible to reduce the intensity and incidence of chronic post-surgical pain in breast cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05494281
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Neoplasms
Currently open trials in the same condition.
- NCT07214532 — Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · NA · recruiting
- NCT07500428 — Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models · recruiting
- NCT07581834 — Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multic · Phase 2 · recruiting
- NCT07222215 — PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) · Phase 2 · recruiting
- NCT07465393 — Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors · NA · recruiting
Other Moroccan Society of Surgery trials
Trials by the same sponsor.
- NCT04607577 — Cross-cultural Adaptation and Validation in Moroccan Arabic Dialect "Darija" of the QoR-15 Postoperative Recovery Qualit · unknown
- NCT04130568 — Translation and Adaptation of Learning Organisation Survey for French Speaking Countries · completed
- NCT04000802 — Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers · completed
- NCT05286411 — Evaluation of the Implementation of a Quality Improvement Program Through Morbidity and Mortality Reviews · completed
- NCT04128657 — Validation of the Moroccan Arabic Version of the Low Anterior Resection Syndrome (LARS) and Wexner Score of Continence A · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05494281 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Moroccan Society of Surgery
- Last refreshed: 22 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05494281.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing